MIO, Catia
 Distribuzione geografica
Continente #
NA - Nord America 2.015
EU - Europa 393
AS - Asia 139
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.551
Nazione #
US - Stati Uniti d'America 2.013
IT - Italia 90
UA - Ucraina 88
BE - Belgio 59
DE - Germania 52
CN - Cina 50
IE - Irlanda 38
TR - Turchia 37
VN - Vietnam 31
SE - Svezia 26
GB - Regno Unito 15
IN - India 10
IR - Iran 10
RU - Federazione Russa 9
FI - Finlandia 8
NL - Olanda 5
CA - Canada 2
CL - Cile 2
CZ - Repubblica Ceca 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
IL - Israele 1
Totale 2.551
Città #
Fairfield 295
Chandler 227
Woodbridge 198
Seattle 141
Wilmington 137
Ashburn 131
Houston 118
Cambridge 111
Ann Arbor 98
Brussels 59
Jacksonville 47
Dearborn 46
Udine 46
Redmond 43
Dublin 38
Izmir 37
Dong Ket 31
Princeton 29
Beijing 26
Des Moines 11
Norwalk 10
San Diego 8
San Mateo 8
Augusta 7
Boardman 7
Falls Church 6
Grafing 6
Leawood 5
Ardabil 4
Hefei 4
London 4
Nanchang 4
Nanjing 4
New York 4
Trento 4
Chengdu 3
Dallas 3
Monmouth Junction 3
Portici 3
Reggio Nell'emilia 3
Bari 2
Brno 2
Castelfranco Veneto 2
Chions 2
Jinan 2
Kashan 2
Mumbai 2
New Delhi 2
Phoenix 2
Tappahannock 2
Tavagnacco 2
Toronto 2
Torre Del Greco 2
Andover 1
Cachoeira do Sul 1
Cadoneghe 1
Changsha 1
Edinburgh 1
Hangzhou 1
Harbin 1
Kunming 1
Monfalcone 1
Montebelluna 1
Napoli 1
Parma 1
Premariacco 1
Rome 1
Sacramento 1
Serio 1
Tel Aviv 1
Venezia 1
Washington 1
Wuhan 1
Zanjan 1
Zhengzhou 1
Totale 2.017
Nome #
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 148
null 146
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 127
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 123
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 121
Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway 119
null 118
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 117
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line 110
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 108
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 108
null 102
null 98
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 98
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 87
null 84
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 70
Analysis of the biological mechanisms de-regulated after pharmacological BET inhibition in a model of anaplastic thyroid cancer 66
null 63
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 61
Molecular defects in thyroid dysgenesis 57
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 57
BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome 55
Missense NR2F1 variant in monozygotic twins affected with the Bosch–Boonstra–Schaaf optic atrophy syndrome 36
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma (Endocrine, (2020), 10.1007/s12020-020-02221-8) 34
Effects of nutraceuticals on anaplastic thyroid cancer cells 33
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation 31
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 31
A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype 29
Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy 28
Validation of a One-Step Reverse Transcription-Droplet Digital PCR (RT-ddPCR) Approach to Detect and Quantify SARS-CoV-2 RNA in Nasopharyngeal Swabs 24
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility 23
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells 22
Expression of PAX8 target genes in papillary thyroid carcinoma 20
A novel de novo HDAC8 missense mutation causing Cornelia de Lange syndrome 18
MCM5 as a target of BET inhibitors in thyroid cancer cells 18
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy 16
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 15
A novel de novo NIPA1 missense mutation associated to hereditary spastic paraplegia 13
Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy 13
Role of m6A RNA Methylation in Thyroid Cancer Cell Lines 10
Pro‐inflammatory microenvironment modulates the transfer of mutated tp53 mediated by tumor exosomes 10
Somatic genomic imbalances in ‘tumour-free’ surgical margins of oral cancer 7
NK2 homeobox gene cluster: Functions and roles in human diseases 6
Novel IGFALS mutations with predicted pathogenetic effects by the analysis of AlphaFold structure 5
Monoallelic variants resulting in substitutions of MAB21L1 Arg51 Cause Aniridia and microphthalmia 3
Reading cancer: Chromatin readers as druggable targets for cancer treatment 1
Totale 2.689
Categoria #
all - tutte 7.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019225 0 0 0 0 2 0 8 22 5 30 101 57
2019/2020796 31 19 58 107 62 92 128 94 89 54 26 36
2020/2021510 24 40 32 44 26 63 29 49 47 29 70 57
2021/2022397 32 40 8 14 14 14 21 27 10 41 137 39
2022/2023450 34 53 5 65 50 113 5 35 54 8 15 13
2023/2024131 21 16 8 8 78 0 0 0 0 0 0 0
Totale 2.689